Cidara Therapeutics, Inc. — Director's Dealing 2015

Apr 15, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2015-04-14

Reporting Person: Bartizal Ken (Chief Development Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	61376	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$6.86	2025-02-18	Common Stock (51377)		Direct

Footnotes

F1: The option is immediately exercisable, with vesting as follows: The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of February 19, 2015 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date.